UK Medical Cannabis: Market Report 2025–2026

The UK medical cannabis market is moving fast. Imports more than doubled in 2025. The teleclinic landscape is consolidating around a handful of large vertically integrated groups. Average flower prices have fallen to £6.95 per gram. And for the first time since legalisation in 2018, the regulatory framework is under formal review.

But the numbers in circulation tell very different stories. Some published estimates put the active patient base above 140,000. Others cite a market worth over £300 million. Understanding which figures to trust — and why — matters if you are making real decisions in or about this market.

Our UK Medical Cannabis Market 2025–2026 report draws on Home Office Freedom of Information data, NHS Business Services Authority dispensing records, CQC findings, and industry estimates to set out what the evidence actually shows. It covers imports and supply chains, patient numbers and access, pricing, product range, the clinic and teleclinic landscape, market sizing, competitive dynamics, the current regulatory environment, and the 2030 outlook.

Every figure carries a confidence grade. Where estimates vary, the methodology is explained. Where claims could not be independently verified against accessible sources, we say so.

Written for clinic operators, importers, pharmacies, investors, and anyone making serious decisions in the UK medical cannabis space.

Download Report (296kb PDF)